Currently we test and support the following browsers:
Please note that this is not intended to be an exhaustive list of browsers that support web standards, nor a test of browser compliance, nor a side-by-side comparison of various manufacturers’ browsers.
Research
Patients with malignant and non-malignant disorders can be treated by autologous or allogeneic stem cell / bone marrow transplant at St. Jude. Our allogeneic transplant program treats patients with acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), juvenile myelomonocytic leukemia (JMML), histiocytosis, sickle cell disease, bone marrow failure syndromes, aplastic anemia, thalassemia, osteopetrosis, osteogeneses imperfecta, metabolic storage disorders, certain high-risk solid tumors, and immunodeficiencies. Our autologous transplant program treats patients with high-risk solid tumors, including neuroblastoma, Ewing sarcoma/primitive neuroectodermal tumor (PNET), rhabdomyosarcoma, desmoplastic small round cell tumor, Wilms tumor, germ cell tumors, lymphomas and brain tumors.
Please contact us if your child’s disease is not listed and you are interested in pursuing a stem cell / bone marrow transplant at St. Jude.
Last update: October 2003
